As psychedelic treatments get leaner, patients' social environments deserve attention
Edward Jacobs, Ian Roullier, Rosalind Watts, Hattie Wells
Zenodo (CERN European Organization for Nuclear Research) March 3, 2026 DOI: 10.5281/zenodo.18852349 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractAs psychedelic treatments become more widely available with less clinical oversight, the psychological support once provided by formal integration sessions may shift to patients' friends and family. This article argues that these social environments likely influence treatment outcomes but have not been studied. It proposes three solutions: educating support networks about psychedelic experiences, creating peer support groups for specific clinical populations, and regularly measuring social-environmental factors in research.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Keywords | Perspective graphical Psychoeducation Social support Perception Social relation |
| Key finding | Argues that patients' social environments are plausible but unmeasured moderators of psychedelic treatment outcomes as clinical support decreases. |
Abstract
As psychedelic treatments approach licensing with reduced clinical intensity, the psychological functions previously served by integration support are increasingly displaced onto patients' social environments. This Perspective argues that these environments are plausible but unmeasured moderators of outcome, and proposes three responses: structured psychoeducation for support networks, purpose-built peer support for clinical populations, and routine incorporation of social-environmental measures into research protocols.